小鵬汽車(09868.HK)首八月在境外46個國家和地區共交付2.47萬輛車 按年增逾1.37倍
小鵬汽車(09868.HK)(XPEV.US)宣佈,今年首八個月在境外46個國家和地區共交付24,702輛車,按年增長超過137%;境外門店翻倍增長至275間。
上述汽車交付在區域分佈計,歐洲佔比總銷售額的52%,中東25%,亞洲21%,拉美也拿下2%的份額。
小鵬於首八個月不僅拿下12個國家和地區的新勢力純電銷量第一,還在32國/地區市場統計中成爲新勢力品牌總銷量榜首,在歐洲小鵬同樣摘得同期新勢力純電銷量冠軍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.